5-MeO-DMT

5-MeO-DMT (5-methoxy-N,N-dimethyltryptamine) is a potent, fast-acting psychedelic tryptamine that acts as a non-selective serotonin receptor agonist, with particularly high affinity for the 5-HT1A and 5-HT2A subtypes. Benuvia operates as a contract development and manufacturing organization (CDMO) that produces high-purity, synthetic, GMP-grade 5-MeO-DMT for use by pharmaceutical and biotech clients in clinical research. The compound is currently being investigated for its therapeutic potential in treating psychiatric conditions such as treatment-resistant depression, anxiety, and post-traumatic stress disorder (PTSD). Unlike longer-acting psychedelics like psilocybin, 5-MeO-DMT is characterized by a rapid onset and short duration of action, often lasting less than 30 minutes.

Other names

5-methoxy-N,N-dimethyltryptamineN,N-Dimethyl-5-Methoxy-Tryptamine